| Patient | Age/sex | Diagnosis | Proximal muscle weakness | DM skin rash | Muscle enzymes | Anti-Jo1 antibodies | Abnormal EMG findings | Abnormal muscle biopsy findings | Medication |
| 1 | 20/F | PM/MCTD | + | − | + | − | − | + | Pred., MTX | 2 | 46/F | PM | + | − | + | − | + | + | Pred., MTX | 3 | 31/F | PM | + | − | + | − | + | + | Pred., MTX | 4 | 65/F | PM | + | − | + | − | + | − | Pred., MTX | 5 | 47/F | PM/ILD | + | − | + | + | NR | + | Pred., MTX, IVIG | 6 | 72/H | PM | + | − | + | − | − | + | Pred. | 7 | 67/F | PM | + | − | + | − | + | + | Pred. | 8 | 27/F | PM/MCTD | + | − | + | − | + | − | Pred., AZA | 9 | 41/H | PM | + | − | + | + | + | + | Pred., MTX | 10 | 72/H | PM/HCV | + | − | + | − | + | + | Pred., IVIG | 11 | 61/F | PM | + | − | + | − | + | + | Pred. | 12 | 38/F | PM/ILD | + | − | + | + | + | + | Pred., MTX | 13 | 61/H | PM | + | − | + | − | + | − | Pred., MTX, IVIG | 14 | 57/F | PM/MCTD | + | − | + | − | + | + | Pred., MTX, chloroquine | 15 | 77/F | PM | + | − | + | − | + | + | Pred. | 16 | 63/H | PM/ILD | + | − | + | + | + | + | Pred. | 17 | 48/F | PM | + | − | + | − | + | − | Pred., MTX, IVIG, AZA | 18 | 37/H | DM | + | + | + | − | + | + | Pred., MTX | 19 | 42/F | DM | + | + | + | − | + | − | Pred., MTX, IVIG | 20 | 56/H | DM | + | + | + | − | + | − | Pred., MTX, chloroquine | 21 | 44/H | DM | + | + | + | − | + | − | Pred., MTX, IVIG | 22 | 14/F | DM | + | + | + | − | + | + | Pred. | 23 | 67/H | DM | + | + | + | − | + | + | Pred. | 24 | 40/F | DM | + | + | + | − | + | + | Pred., MTX | 25 | 40/F | DM | + | + | + | + | + | + | Pred., MTX, IVIG, AZA, CSA | 26 | 74/H | IBM | + | − | + | − | + | + | Pred. | 27 | 69/F | IBM | + | − | + | − | + | + | Pred., MTX, IVIG |
|
|